Other functions - a novel tumor paint for tumor resection

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201200054C
Awardee
Awarding agency
Obligated
$248,551

Award facts

Opportunity
  • PHS201201 Solicitation number
Contract value 100% obligated
$248,551.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Seattle, WA 98109, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $248,551

About this award

The National Cancer Institute (NCI) awarded a $248,551 firm-fixed-price definitive contract to Blaze Bioscience, Inc. for the development of a "Novel Tumor Paint for Tumor Resection." This contract, which does not have a set-aside designation, was awarded on September 14, 2012, with a period of performance ending on September 13, 2013. Blaze Bioscience, Inc. is a for-profit organization based in Seattle, Washington. The contract is focused on "Other Functions" related to the NCI's cancer research and treatment programs.

Quick answers

Who was awarded contract HHSN261201200054C?

HHSN261201200054C was awarded to Blaze Bioscience, Inc. by National Cancer Institute (National Institutes of Health) on September 14, 2012.

How much is contract HHSN261201200054C worth?

The government has obligated $248,551 on HHSN261201200054C.

Was contract HHSN261201200054C competed?

The extent of competition for HHSN261201200054C was full and open competition. The government received 8 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award